Publication | Closed Access

Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage

Cannabis UsePsychoactive DrugCognitive DamageCognitive PerformanceAddictionMedicinePsychopharmacologyNeuropharmacologyPost-conditioning TreatmentNeuroscienceUltra-low DosePharmacologyCannabinoid PharmacologyCannabinoidsSocial SciencesCannabis